Effects of Albumin Treatment on Systemic and Portal Hemodynamics and Systemic Inflammation in Patients With Decompensated Cirrhosis.

Albumin reduces paracentesis-induced circulatory dysfunction and reduces death and renal impairment among patients with cirrhosis and infection: A systematic review and meta-analysis

Kwok, Chun Shing
Krupa, Lukasz
Mahtani, Ash
Kaye, Duncan
Rushbrook, Simon M.
Phillips, Martin G.
Gelson, William

January 2013

Background. Studies have suggested that albumin has a value in cirrhotic patients undergoing paracen...

A Randomized Trial of Albumin Infusions in Hospitalized Patients with Cirrhosis

China, Louise
Freemantle, Nick
Forrest, Ewan
Kallis, Yiannis
Ryder, Stephen D
Wright, Gavin
Portal, Andrew J
Becares Salles, Natalia
Gilroy, Derek W
SKENE, SIMON
O'Brien, Alastair

March 2021

Infection and increased systemic inflammation cause organ dysfunction and death in patients with dec...

Human albumin in the management of complications of cirrhosis.

Bernardi M
Maggioli C
Zaccherini G.

January 2012

Human serum albumin is the most abundant plasma protein, representing about 50% of the total protein...

Effects of albumin treatment on systemic and portal hemodynamics and systemic inflammation in patients with decompensated cirrhosis

Fernández, Javier
Clària, Joan
Amorós, Alex
Aguilar, Ferrán
Castro, Miriam
Casulleras, Mireia
Acevedo, Juan
Duran-Güell, Marta
Nuñez, Laura
Costa, Montserrat
Torres, Mireia
Horrillo, Raquel
Ruiz-del-Árbol, Luis
Villanueva, Cándido
Prado, Verónica
Arteaga, Mireya
Trebicka, Jonel
Angeli, Paolo
Merli, Manuela
Alessandria, Carlo
Aagaard, Niels Kristian
Soriano, German
Durand, François
Gerbes, Alexander L.
Gustot, Thierry
Welzel, Tania Mara
Salerno, Francesco
Bañares, Rafael
Vargas Blasco, Victor Manuel
Albillos, Agustin
Silva, Aníbal
Morales-Ruiz, Manuel
García-Pagán, Juan Carlos
Pavesi, Marco
Jalan, Rajiv
Bernardi, Mauro
Moreau, Richard
Páez, Antonio
Arroyo, Vicente

March 2019

Background & Aims: We investigated the effect of albumin treatment (20% solution) on hypoalbuminemia...

Effects of Albumin Treatment on Systemic and Portal Hemodynamics and Systemic Inflammation in Patients With Decompensated Cirrhosis

Fernández, Javier
Clària, Joan
Amorós, Alex
Aguilar, Ferrán
Castro, Miriam
Casulleras, Mireia
Acevedo, Juan
Duran-Güell, Marta
Nuñez, Laura
Costa, Montserrat
Torres, Mireia
Horrillo, Raquel
Ruiz-Del-Árbol, Luis
Villanueva, Cándido
Prado, Verónica
Arteaga, Mireya
Trebicka, Jonel
Angeli, Paolo
Merli, Manuela
Alessandria, Carlo
Aagaard, Niels Kristian
Soriano, German
Durand, François
Gerbes, Alexander
Gustot, Thierry
Welzel, Tania M
Salerno, Francesco
Bañares, Rafael
Vargas, Victor
Albillos, Agustin
Silva, Aníbal
Morales-Ruiz, Manuel
Pavesi, Marco
Jalan, Rajiv
Bernardi, Mauro
Moreau, Richard
Páez, Antonio
Arroyo, Vicente

January 2019

We investigated the effect of albumin treatment (20% solution) on hypoalbuminemia, cardiocirculatory...

The role and indications of albumin in advanced liver disease

Zaccherini, G
Bernardi, M

January 2019

Low serum albumin is common in cirrhosis and is associated with a reduced survival. Moreover, in thi...

Albumin in decompensated cirrhosis: New concepts and perspectives

Bernardi M.
Angeli P.
Claria J.
Moreau R.
Gines P.
Jalan R.
Caraceni P.
Fernandez J.
Gerbes A. L.
O'Brien A. J.
Trebicka J.
Thevenot T.
Arroyo V.

January 2020

The pathophysiological background of decompensated cirrhosis is characterised by a systemic proinfla...

Role of albumin in diseases associated with severe systemic inflammation: Pathophysiologic and clinical evidence in sepsis and in decompensated cirrhosis

Artigas, Antonio
Wernerman, Jan
Arroyo, Vicente
Vincent, Jean Louis
Levy, Mitchell

June 2016

The metabolism of albumin in inflammatory states such as sepsis or major surgery is complex and stil...

Pathophysiological basis of albumin use in cirrhosis

Vicente Arroyo
Javier Fernandez

January 2011

During the course of cirrhosis, a progressive reduction of splanchnic vascular resistance takes plac...

Human serum albumin, systemic inflammation, and cirrhosis

Arroyo, Vicente
García-Martinez, Rita
Salvatella, Xavier

August 2014

SummaryHuman serum albumin (HSA) is one of the most frequent treatments in patients with decompensat...

New Insights About Albumin and Liver Disease

Joana R. Carvalho
Mariana Verdelho Machado

July 2018

Decompensated liver cirrhosis has a dismal prognosis, with an overall survival of 2-4 years, which i...

Albumin: Pathophysiologic basis of its role in the treatment of cirrhosis and its complications.

Garcia Martinez R
Ginés P
Arroyo V
Jalan R.
CARACENI, PAOLO
BERNARDI, MAURO

January 2013

Since the introduction of human serum albumin as a plasma expander in the 1940s, considerable resear...

Albumin Administration is Efficacious in the Management of Patients with Cirrhosis: A Systematic Review of the Literature

Giacomo Zaccherini
Manuel Tufoni
Mauro Bernardi

January 2020

The use of albumin in patients with cirrhosis has been extensively discussed over recent years. Curr...

Hemodynamic and Systemic Effects of Albumin in Patients with Advanced Liver Disease

Tufoni, Manuel
Baldassarre, Maurizio
Zaccherini, Giacomo
Antognoli, Agnese
Caraceni, Paolo

January 2020

Purpose of Review: Albumin administration is recommended to prevent or treat specific complications ...

Albumin Reduces Paracentesis-Induced Circulatory Dysfunction and Reduces Death and Renal Impairment among Patients with Cirrhosis and Infection: A Systematic Review and Meta-Analysis

Chun Shing Kwok
Lukasz Krupa
Ash Mahtani
Duncan Kaye
Simon M. Rushbrook
Martin G. Phillips
William Gelson

January 2013

Background. Studies have suggested that albumin has a value in cirrhotic patients undergoing paracen...

Albumin reduces paracentesis-induced circulatory dysfunction and reduces death and renal impairment among patients with cirrhosis and infection: A systematic review and meta-analysis

Kwok, Chun Shing
Krupa, Lukasz
Mahtani, Ash
Kaye, Duncan
Rushbrook, Simon M.
Phillips, Martin G.
Gelson, William

January 2013

Background. Studies have suggested that albumin has a value in cirrhotic patients undergoing paracen...

A Randomized Trial of Albumin Infusions in Hospitalized Patients with Cirrhosis

China, Louise
Freemantle, Nick
Forrest, Ewan
Kallis, Yiannis
Ryder, Stephen D
Wright, Gavin
Portal, Andrew J
Becares Salles, Natalia
Gilroy, Derek W
SKENE, SIMON
O'Brien, Alastair

March 2021

Infection and increased systemic inflammation cause organ dysfunction and death in patients with dec...

Human albumin in the management of complications of cirrhosis.

Bernardi M
Maggioli C
Zaccherini G.

January 2012

Human serum albumin is the most abundant plasma protein, representing about 50% of the total protein...

Effects of albumin treatment on systemic and portal hemodynamics and systemic inflammation in patients with decompensated cirrhosis

Fernández, Javier
Clària, Joan
Amorós, Alex
Aguilar, Ferrán
Castro, Miriam
Casulleras, Mireia
Acevedo, Juan
Duran-Güell, Marta
Nuñez, Laura
Costa, Montserrat
Torres, Mireia
Horrillo, Raquel
Ruiz-del-Árbol, Luis
Villanueva, Cándido
Prado, Verónica
Arteaga, Mireya
Trebicka, Jonel
Angeli, Paolo
Merli, Manuela
Alessandria, Carlo
Aagaard, Niels Kristian
Soriano, German
Durand, François
Gerbes, Alexander L.
Gustot, Thierry
Welzel, Tania Mara
Salerno, Francesco
Bañares, Rafael
Vargas Blasco, Victor Manuel
Albillos, Agustin
Silva, Aníbal
Morales-Ruiz, Manuel
García-Pagán, Juan Carlos
Pavesi, Marco
Jalan, Rajiv
Bernardi, Mauro
Moreau, Richard
Páez, Antonio
Arroyo, Vicente

March 2019

Background & Aims: We investigated the effect of albumin treatment (20% solution) on hypoalbuminemia...

Effects of Albumin Treatment on Systemic and Portal Hemodynamics and Systemic Inflammation in Patients With Decompensated Cirrhosis

Fernández, Javier
Clària, Joan
Amorós, Alex
Aguilar, Ferrán
Castro, Miriam
Casulleras, Mireia
Acevedo, Juan
Duran-Güell, Marta
Nuñez, Laura
Costa, Montserrat
Torres, Mireia
Horrillo, Raquel
Ruiz-Del-Árbol, Luis
Villanueva, Cándido
Prado, Verónica
Arteaga, Mireya
Trebicka, Jonel
Angeli, Paolo
Merli, Manuela
Alessandria, Carlo
Aagaard, Niels Kristian
Soriano, German
Durand, François
Gerbes, Alexander
Gustot, Thierry
Welzel, Tania M
Salerno, Francesco
Bañares, Rafael
Vargas, Victor
Albillos, Agustin
Silva, Aníbal
Morales-Ruiz, Manuel
Pavesi, Marco
Jalan, Rajiv
Bernardi, Mauro
Moreau, Richard
Páez, Antonio
Arroyo, Vicente

January 2019

We investigated the effect of albumin treatment (20% solution) on hypoalbuminemia, cardiocirculatory...

The role and indications of albumin in advanced liver disease

Zaccherini, G
Bernardi, M

January 2019

Low serum albumin is common in cirrhosis and is associated with a reduced survival. Moreover, in thi...

Albumin in decompensated cirrhosis: New concepts and perspectives

Bernardi M.
Angeli P.
Claria J.
Moreau R.
Gines P.
Jalan R.
Caraceni P.
Fernandez J.
Gerbes A. L.
O'Brien A. J.
Trebicka J.
Thevenot T.
Arroyo V.

January 2020

The pathophysiological background of decompensated cirrhosis is characterised by a systemic proinfla...

Role of albumin in diseases associated with severe systemic inflammation: Pathophysiologic and clinical evidence in sepsis and in decompensated cirrhosis

Artigas, Antonio
Wernerman, Jan
Arroyo, Vicente
Vincent, Jean Louis
Levy, Mitchell

June 2016

The metabolism of albumin in inflammatory states such as sepsis or major surgery is complex and stil...

Pathophysiological basis of albumin use in cirrhosis

Vicente Arroyo
Javier Fernandez

January 2011

During the course of cirrhosis, a progressive reduction of splanchnic vascular resistance takes plac...

Human serum albumin, systemic inflammation, and cirrhosis

Arroyo, Vicente
García-Martinez, Rita
Salvatella, Xavier

August 2014

SummaryHuman serum albumin (HSA) is one of the most frequent treatments in patients with decompensat...

New Insights About Albumin and Liver Disease

Joana R. Carvalho
Mariana Verdelho Machado

July 2018

Decompensated liver cirrhosis has a dismal prognosis, with an overall survival of 2-4 years, which i...

Albumin: Pathophysiologic basis of its role in the treatment of cirrhosis and its complications.

Garcia Martinez R
Ginés P
Arroyo V
Jalan R.
CARACENI, PAOLO
BERNARDI, MAURO

January 2013

Since the introduction of human serum albumin as a plasma expander in the 1940s, considerable resear...

Albumin Administration is Efficacious in the Management of Patients with Cirrhosis: A Systematic Review of the Literature

Giacomo Zaccherini
Manuel Tufoni
Mauro Bernardi

January 2020

The use of albumin in patients with cirrhosis has been extensively discussed over recent years. Curr...

Hemodynamic and Systemic Effects of Albumin in Patients with Advanced Liver Disease

Tufoni, Manuel
Baldassarre, Maurizio
Zaccherini, Giacomo
Antognoli, Agnese
Caraceni, Paolo

January 2020

Purpose of Review: Albumin administration is recommended to prevent or treat specific complications ...

Albumin Reduces Paracentesis-Induced Circulatory Dysfunction and Reduces Death and Renal Impairment among Patients with Cirrhosis and Infection: A Systematic Review and Meta-Analysis

Chun Shing Kwok
Lukasz Krupa
Ash Mahtani
Duncan Kaye
Simon M. Rushbrook
Martin G. Phillips
William Gelson

January 2013

Background. Studies have suggested that albumin has a value in cirrhotic patients undergoing paracen...

Albumin reduces paracentesis-induced circulatory dysfunction and reduces death and renal impairment among patients with cirrhosis and infection: A systematic review and meta-analysis

Kwok, Chun Shing
Krupa, Lukasz
Mahtani, Ash
Kaye, Duncan
Rushbrook, Simon M.
Phillips, Martin G.
Gelson, William

January 2013

Background. Studies have suggested that albumin has a value in cirrhotic patients undergoing paracen...

A Randomized Trial of Albumin Infusions in Hospitalized Patients with Cirrhosis

China, Louise
Freemantle, Nick
Forrest, Ewan
Kallis, Yiannis
Ryder, Stephen D
Wright, Gavin
Portal, Andrew J
Becares Salles, Natalia
Gilroy, Derek W
SKENE, SIMON
O'Brien, Alastair

March 2021

Infection and increased systemic inflammation cause organ dysfunction and death in patients with dec...

Human albumin in the management of complications of cirrhosis.

Bernardi M
Maggioli C
Zaccherini G.

January 2012

Human serum albumin is the most abundant plasma protein, representing about 50% of the total protein...

Effects of Albumin Treatment on Systemic and Portal Hemodynamics and Systemic Inflammation in Patients With Decompensated Cirrhosis.

Abstract

Extracted data

Effects of Albumin Treatment on Systemic and Portal Hemodynamics and Systemic Inflammation in Patients With Decompensated Cirrhosis.

Abstract

Extracted data

Related items

Related items